MEDICATION IN EARLY-PREGNANCY - PREVALENCE OF USE AND RELATIONSHIP TO MATERNAL CHARACTERISTICS

被引:54
作者
BUITENDIJK, S
BRACKEN, MB
机构
[1] YALE UNIV,PERINATAL EPIDEMIOL UNIT,NEW HAVEN,CT 06520
[2] YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,NEW HAVEN,CT 06510
[3] YALE UNIV,SCH MED,DEPT OBSTET & GYNECOL,NEW HAVEN,CT 06510
关键词
DRUGS; MEDICATIONS; RISK-TAKING BEHAVIOR; PREGNANCY;
D O I
10.1016/0002-9378(91)90218-G
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Medication use was assessed in a population of 4186 women who were delivered of infants at Yale-New Haven Hospital, New Haven, Connecticut, between 1980 and 1982. The frequency of over-the-counter and prescription drug use, and the association of such use with maternal characteristics was studied. Of all women, 66% used at least one drug. The mean number of drugs used by all subjects was 1.3 and, among drug users, 2.9. Of all drugs used, 68% were over-the-counter and 32% were prescription preparations. Internal analgesics, autonomic drugs, antiinfective agents, and antacids were most frequently used. Women who used prescription drugs were also more likely to use over-the-counter medications. Maternal characteristics that were associated with an increase in both over-the-counter and prescription drug use were being white, smoking more than 20 cigarettes a day, using alcohol, using caffeine, and smoking marijuana. These findings suggest that women who engage in "risk-taking behavior" during pregnancy are also more likely to use medications while pregnant.
引用
收藏
页码:33 / 40
页数:8
相关论文
共 15 条
[1]   STUDIES ON DETECTION OF ADVERSE DRUG REACTIONS IN NEWBORN .2. EFFECTS OF PRENATAL ASPIRIN ON NEWBORN HEMOSTASIS [J].
BLEYER, WA ;
BRECKENRIDGE, RT .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1970, 213 (12) :2049-+
[2]   LOW-BIRTH-WEIGHT IN PREGNANCIES FOLLOWING INDUCED-ABORTION - NO EVIDENCE FOR AN ASSOCIATION [J].
BRACKEN, MB ;
HELLENBRAND, KG ;
HOLFORD, TR ;
BRYCEBUCHANAN, C .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1986, 123 (04) :604-613
[3]  
BRACKEN MB, 1989, EFFECTIVE CARE PREGN
[4]   DRUG PRESCRIBING DURING PREGNANCY - CONTROLLED-STUDY OF TENNESSEE MEDICAID RECIPIENTS [J].
BROCKLEBANK, JC ;
RAY, WA ;
FEDERSPIEL, CF ;
SCHAFFNER, W .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1978, 132 (03) :235-244
[5]  
CORBY DG, 1971, INFANTS J PEDIATR, V79, P307
[6]  
FORFAR JO, 1973, CLIN PHARMACOL THER, V14, P632
[7]  
Heinonen O., 1977, BIRTH DEFECTS DRUGS, P286
[8]  
KELSEY JL, 1986, METHODS OBSERVATIONA, P113
[9]  
KULLANDER S, 1976, ACTA OBSTET GYNECOL, V35, P25
[10]   PRESCRIPTION DRUG-USE BEFORE AND DURING PREGNANCY IN A MEDICAID POPULATION [J].
PIPER, JM ;
BAUM, C ;
KENNEDY, DL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 157 (01) :148-156